Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

San Diego, California--(Newsfile Corp. - October 25, 2022) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rite Aid Corporation (NYSE: RAD) securities between April 14, 2022 and September 28, 2022, inclusive (the "Class Period") have until December 19, 2022 to seek appointment as lead plaintiff in the Rite Aid class action lawsuit. Captioned Page v. Rite Aid Corporation, No. 22-cv-04201 (E.D. Pa.

INVESTOR ALERT: Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RAD

NEW YORK--(BUSINESS WIRE)---- $RAD #classaction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD) securities between April 14, 2022 through September 28, 2022 (the “Class Period”).

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Rite Aid Corporation (RAD) Investors

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the “Class Period”).

EQUITY ALERT: Rosen Law Firm Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAD

Rite Aid (RAD) remains well-placed on online strength, increased non-COVID prescriptions and cost initiatives despite muted COVID-19 testing and vaccine demand, and supply-chain issues.

Online Strength to Drive Rite Aid (RAD) Amid Supply-Chain Woes

LOS ANGELES, CA / ACCESSWIRE / October 24, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rite Aid Corporation ("Rite Aid" or "the Company") (NYSE:RAD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses to Contact the Firm

SAN DIEGO , Oct. 21, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rite Aid Corporation (NYSE: RAD) securities between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period") have until December 19, 2022 to seek appointment as lead plaintiff in the Rite Aid class action lawsuit. Captioned Page v.

INVESTOR NOTICE: Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RAD

SAN DIEGO--(BUSINESS WIRE)---- $RAD #RAD--Rite Aid Corporation (RAD) Misrepresented the Number of New Members Added by its Elixir Subsidiary

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Rite Aid Corporation (RAD)

Did you lose money on investments in Rite Aid? If so, please visit Rite Aid Corporation Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.

RITE AID CORPORATION (RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Rite Aid Corporation (RAD)

CVS Health

Walgreens

The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain from the growing demand for digital healthcare support. However, reimbursement challenges are hurting overall industry health.

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Rite Aid business and prospects, resulting in its stock trading at inflated prices.

INVESTOR ALERT: Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead the Rite Aid Class Action Lawsuit - RAD

LOS ANGELES--(BUSINESS WIRE)---- $RAD #RAD--The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

NEW YORK , Oct. 19, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 22-cv-04201, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Rite Aid securities between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Pomerantz Law Firm Announces the Filing of a Class Action Against Rite Aid Corporation and Certain Officers - RAD

Blue Apron

FaZe Holdings Inc

Party City Holdco

Short interest penny stocks to watch right now. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 4 Short Squeeze Stocks To Watch Today

PHILADELPHIA--(BUSINESS WIRE)--With flu and respiratory illnesses expected to increase during fall and winter months, Rite Aid (NYSE: RAD) is making diagnostic testing easier for Michigan customers with rapid point-of-care testing now available at all stores throughout the state.

Rite Aid Offers Point-of-Care Testing Throughout Michigan

PHILADELPHIA--(BUSINESS WIRE)--Following FDA authorization and new CDC recommendations, Rite Aid (NYSE: RAD) locations, including Bartell Drugs in the Pacific Northwest, are now offering updated boosters of the Pfizer-BioNTech and Moderna COVID-19 vaccines for children ages five years and older.

Scheduling for COVID-19 Updated Boosters for Children Ages Five and Older Now Available at Rite Aid and Bartell Drug Locations

PHILADELPHIA--(BUSINESS WIRE)--Halloween is lurking around the corner and in honor of the spooky season, Rite Aid has released surprising findings on consumers' favorite trick-or-treating novelties and seasonal shopping habits.

Rite Aid Releases ‘Trick-or-Trivia' on Candy Consumptions

Bio-Rad Laboratories

Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this year, significantly underperforming the broader S&P500 index, down 24%.

Should You Buy Bio-Rad Laboratories Stock After Its 50% Fall This Year?

Google Cloud technologies to help Rite Aid make its pharmacies more personalized, data-driven, and resilient PHILADELPHIA and SUNNYVALE, Calif. , Oct. 11, 2022 /PRNewswire/ -- Rite Aid (NYSE: RAD) and Google Cloud today announced a new, multi-year technology partnership that will help Rite Aid realize its vision of a modern pharmacy.

Rite Aid and Google Cloud Partner to Modernize Pharmacy Operations and Enhance the Online Customer Experience

New York, New York--(Newsfile Corp. - October 8, 2022) - Pomerantz LLP is investigating claims on behalf of investors of Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Rite Aid and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Rite Aid Corporation - RAD

OAKLAND, Calif.--(BUSINESS WIRE)---- $RAD #RAD--Gibbs Law Group is investigating potential claims on behalf of Rite Aid (RAD) Investors.

Lost Money in Rite Aid Corp.?

Rite Aid is contemplating putting all store goods in showcases in New York City in an effort to curb retail theft, according to a report from Fox 5 New York.

Rite Aid may place all store items in showcases due to theft in New York City

Will Rite Aid stock ever recover? Unless Rite Aid can improve its revenue, the best advice for investors may involve staying away from the stock.

Rite-Aid Sings a Familiar Tune That Investors Don't Want to Hear

Rite Aid said losses from inventory "shrink," or theft, increased by $5 million.

Rite Aid bosses blame out-of-control NYC shoplifting for $5M revenue hit

Rite Aid's chief retail officer addressed the difficulty facing the chain's NYC stories concerning shoplifting.

Rite Aid exec: Impossible to stop NYC store thefts

Rite Aid (RAD) posts lower Q2 revenues from the year-ago fiscal quarter's level due to sluggishness in both the Retail Pharmacy and Pharmacy Services segments.

News for Rite Aid Stock (RAD)